3 Stocks I Saw on T...
Health Care: Health Services
Covidien PLC (COV: NYSE)
$52.16 -0.31 | -0.59%
02/09/12 - 02:50 PM ET
1.24M / 3.50M
Vol / Avg. Vol:52.53 / 52.47
Open / Prev. Close:51.90 - 52.64
Today's Range:41.35 - 57.65
52 Wk Range:16.57%
Performance YTD:TheStreet Rating:
Portfolios with COV
- Portfolio NameUser Type
- ContributorTop-Yielding Health Service...
- ProPrivate Capital Management
- ProJana Partners
- ContributorJohn Paulson's 10 Best New ...
- Contributor8 Health Care Stocks to Buy
- ProTPG-Axon Capital
- ProKaren Finerman - Metropolit...
- ContributorDividend Stocks for the Wee...
- Contributor8 Top-Rated Diversified Stocks
- ProSAC Capital
Latest COV Headlines from TheStreet
- Cramer's 'Mad Money' Recap: Balancing Act (Final) 02.08.12 | 07:02 pm
- 'Mad Money Lightning Round': Get Some Covidien 02.08.12 | 07:02 pm
- Covidien Plc's CEO Discusses Q1 2012 Results - Earnings Call Transcript 01.26.12 | 02:01 pm
- Pharmaceutical Earnings Outlook
01.26.12 | 09:01 am - Covidien Stock To Go Ex-dividend Tomorrow (COV) 01.25.12 | 10:01 am
- Analysts' Actions: EMC, BEN, MSFT, BP, BLK 01.12.12 | 10:01 am
- Covidien Plc Presents At The 30th Annual JPMorgan Chase Healthcare Conference, Jan-09-2012 08:30 AM 01.09.12 | 06:01 pm
- 3 Stocks I Saw on TV, December 20 12.20.11 | 08:12 am
- Cramer's 'Mad Money' Recap: No Saving Europe (Final) 12.19.11 | 06:12 pm
- 'Fast Money' Recap: 'Death Knell' for RIM? 12.15.11 | 08:12 pm
Press Releases for COV
- Covidien To Present At Leerink Swann Conference - Business Wire 02.09.12 | 07:02 am
- Results From Solitaire With The Intention For Thrombectomy (SWIFT) Study Announced At The International Stroke Conference On February 3 - Business Wire 02.03.12 | 06:02 am
- Results From Solitaire With The Intention For Thrombectomy (SWIFT) Study Announced At The International Stroke Conference On February 3 - Business Wire 02.01.12 | 05:02 pm
- Covidien Revascularization Device Approved For Interventional Management Of Stroke Trial - Business Wire 01.30.12 | 07:01 am
- Covidien Reports First-Quarter Results - Business Wire 01.26.12 | 06:01 am
- Clinical Data For DURABILITY II Study Presented At ISET 2012 - Business Wire 01.24.12 | 04:01 pm
- Covidien Releases Clinical Data On Plaque Excision For The Treatment Of Calcified Lesions - Business Wire 01.23.12 | 05:01 pm
- Covidien Appoints New Leader For Vascular Therapies Business - Business Wire 01.23.12 | 07:01 am
- Jose E. Almeida, Covidien Plc (Photo: Business Wire) - Business Wire 01.20.12 | 07:01 am
- Covidien Declares Quarterly Cash Dividend - Business Wire 01.19.12 | 04:01 pm
Partner Headlines for COV
- Cardica's Losses Trim in 2Q - Analyst Blog - Zacks 02.08.12 | 09:02 am
- Covidien Plays To Its Strengths And Still Looks Undervalued - Seeking Alpha 01.27.12 | 08:01 am
- Clinical Data for DURABILITY II Study Presented at ISET 2012; Met Predetermined VPI Performance Goals - Benzinga 01.24.12 | 04:01 pm
- 10 Solid Value Stocks That FPA Crescent Fund Holds - Seeking Alpha 01.07.12 | 03:01 am
- Covidien to Spin off Pharma Biz - Analyst Blog - Zacks 12.19.11 | 10:12 am
- Covidien, Abbott Setting A Spin-Out Trend - Seeking Alpha 12.18.11 | 09:12 am
- Zweig DiMenna's Top Stock Picks - Seeking Alpha 12.09.11 | 07:12 am
- Bottom Feeding: 5 Stocks Trading At 52 Week Lows - Seeking Alpha 12.02.11 | 08:12 am
- Earnings Scorecard: Covidien - Analyst Blog - Zacks 11.25.11 | 04:11 pm
- Stock Ranking According To Hedge Fund Investing (Part 3) - Seeking Alpha 11.24.11 | 05:11 am
